Net Cash Provided by (Used in) Operating Activities |
252K |
USD |
-93.8% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-560K |
USD |
+71.8% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
200M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
8.48M |
shares |
-5.07% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-308K |
USD |
-115% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
754K |
USD |
-66.8% |
Q2 2025 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
37K |
USD |
+23.9% |
Q1 2024 |
Q1 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Gross |
58.4K |
USD |
|
Q2 2025 |
Q2 2025 |
Deferred Income Tax Expense (Benefit) |
-164K |
USD |
-188% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
0 |
USD |
|
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Current Income Tax Expense (Benefit) |
0 |
USD |
|
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Authorized |
25M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Additional Paid in Capital |
76.1M |
USD |
-6.27% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |